Western blot analysis of extracts from HepG2 tissue using Phospho-PDCD4 (Ser67) Antibody. The lane on the right is treated with the antigen-specific peptide.
Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA1) Kakade D, Islam N, Maeda N, Adegoke OA (2014)BMC Cell Biol 15, 2 . Dorrello NV, et al. (2006)Science 314, 467-71. Palamarchuk A, et al. (2005)Cancer Res 65, 11282-6.
Immunogen
PDCD4 (phospho Ser67) antibody was raised against a peptide sequence around phosphorylation site of serine 67 (K-N-S (p)-S-R) derived from Human PDCD4 .
Western blot analysis of extracts from HepG2 tissue using Phospho-PDCD4 (Ser67) Antibody. The lane on the right is treated with the antigen-specific peptide.
Application Notes
Western Blot: 1:500~1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store antibody at -20˚C for up to one year.
Storage Buffer
Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.